Over the last two decades virus‑like particles (VLPs) have become an important tool in
biomedical research and medicine. VLPs are multi‑protein structures that resemble viable …

Chemically and/or genetically engineered viruses, viral capsids and viral-like particles carry
the promise of important and diverse applications in biomedicine, biotechnology and …

Viral infectious diseases threaten human health and global stability. Several vaccine
platforms, such as DNA, mRNA, recombinant viral vectors, and virus-like particle-based …

Virus-like particles (VLPs) can be spontaneously self-assembled by viral structural proteins
under appropriate conditions in vitro while excluding the genetic material and potential …

Over the last three decades, virus-like particles (VLPs) have evolved to become a widely
accepted technology, especially in the field of vaccinology. In fact, some VLP-based …

Highlights•VLP have been engineered to improve their utility as vaccine platforms.•Targeted
engineering of VLPs has enhanced immunogenicity, stability, and versatility.•Predictive …

Virus-like particles (VLPs) are nanostructures assemble from viral proteins. Besides widely
used for vaccine development, VLPs have also been explored as nanocarriers for cargo …

This book represents the first complete and systematic guide to the virus-like particles
(VLPs) and their applications as vaccines, therapeutic tools, nanomaterials, and …

Virus-like particle (VLP) technology is a promising approach for the construction of novel
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …

Viruses naturally exhibit an incredible variety of sophisticated nanostructures, which makes
them ideal biological building blocks for nanoengineered material research. By mimicking …